OrbiMed Advisors »

Astrazeneca Plc Ord shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Astrazeneca Plc Ord (AZN) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Astrazeneca Plc Ord

Tip: Access up to 7 years of quarterly data

All positions including Astrazeneca Plc Ord held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astrazeneca Plc Ord by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $132M 670k 197.22

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding Astrazeneca Plc Ord

Investor AB
Vanguard Capital Management
Capital Research and Management Company - Division 3
Capital World Investors
Legal & General Group
Bank of America Corporation
Vanguard Asset Management
PRIMECAP Management Company
Franklin Resources
Amundi
Vanguard Fiduciary Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Deutsche Bank Aktiengesellschaft
Henderson Group
Aviva

View all funds holding Astrazeneca Plc Ord